Integration of methylation QTL and enhancer-target gene maps with schizophrenia GWAS summary results identifies novel genes.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30850848.
- Also identified by DOI 10.1093/bioinformatics/btz161 and PMC identifier 6761938.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most trait-associated genetic variants identified in genome-wide association studies (GWASs) are located in non-coding regions of the genome and thought to act through their regulatory roles. To account for enriched association signals in DNA regulatory elements, we propose a novel and general gene-based association testing strategy that integrates enhancer-target gene pairs and methylation quantitative trait locus data with GWAS summary results; it aims to both boost statistical power for new discoveries and enhance mechanistic interpretability of any new discovery. By reanalyzing two large-scale schizophrenia GWAS summary datasets, we demonstrate that the proposed method could identify some significant and novel genes (containing no genome-wide significant SNPs nearby) that would have been missed by other competing approaches, including the standard and some integrative gene-based association methods, such as one incorporating enhancer-target gene pairs and one integrating expression quantitative trait loci. Software: wuchong.org/egmethyl.html. Supplementary data are available at Bioinformatics online.
Medical subject headings
- Genome-Wide Association Study
- Schizophrenia